Bernard Coulie, President and CEO at PLIANT THERAPEUTICS, INC. (PLRX), sold 74,895 shares at $34.92 ($2.6M) on 2023-01-31, disclosed to the SEC on 2023-02-01.
Open-market sale of $2.6M PLRX by President and CEO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $33.98 | 11,395 | $387K | 15.0% |
| 2 | $33.98 | 11,395 | $387K | 15.0% |
| 3 | $34.66 | 3,605 | $125K | 4.9% |
| 4 | $34.66 | 3,605 | $125K | 4.9% |
| 5 | $34.92 | 15,000 | $524K | 20.3% |
| 6 | $34.15 | 9,455 |
| $323K |
| 12.5% |
| 7 | $34.15 | 9,455 | $323K | 12.5% |
| 8 | $34.78 | 5,440 | $189K | 7.3% |
| 9 | $34.78 | 5,440 | $189K | 7.3% |
| 10 | $35.55 | 105 | $4K | 0.1% |
| Total | $34.40 avg | 74,895 | $2.6M | 100% |
| Filing → |
| PLRX | SELL | 2024-07-12 | $895K | — | Filing → |
| PLRX | SELL | 2024-01-19 | $886K | — | Filing → |
| PLRX | SELL | 2023-07-19 | $2.5M | — | Filing → |